Ensure the safety and quality of your research peptides with our comprehensive contaminant testing services. We screen for heavy metals, residual solvents, and bacterial endotoxins that could compromise experimental results or pose safety risks. Available now for researchers, compounding pharmacies, and biotech companies nationwide.
ICP-MS screening for lead, mercury, cadmium, arsenic, and other heavy metals at parts-per-billion detection limits. Results in 5-7 business days.
GC-MS analysis per ICH Q3C guidelines to detect and quantify TFA, DMF, DCM, acetonitrile, and other residual solvents from peptide synthesis.
Combined heavy metal + residual solvent analysis in a single submission for a complete safety profile. Ideal for regulatory submissions and quality programs.
Quantitative LAL assay for bacterial endotoxin detection and quantification per USP <85>. Essential for injectable peptides and cell culture research. See endotoxin testing details →
Even high-purity peptides can contain trace contaminants that interfere with biological assays, cell culture experiments, or in vivo studies. Our testing helps identify:
Ensure contaminants aren't confounding your experimental results, especially for cell-based assays and in vivo studies.
Verify raw material safety and meet USP requirements for heavy metal and solvent limits in compounded preparations.
Validate manufacturing quality with independent contaminant screening to build customer trust and meet regulatory standards.
Support IND-enabling studies and regulatory submissions with ICH-compliant contaminant data from an independent lab.
ICP-MS heavy metal screening and GC-MS residual solvent analysis, 5-7 business day turnaround, nationwide service.